Low-cost anti-mycobacterial drug discovery using engineered E. coli.
利用基因工程改造的大肠杆菌进行低成本抗分枝杆菌药物研发
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-022-31570-3
Bongaerts Nadine, Edoo Zainab, Abukar Ayan A, Song Xiaohu, Sosa-Carrillo Sebastián, Haggenmueller Sarah, Savigny Juline, Gontier Sophie, Lindner Ariel B, Wintermute Edwin H